Introduction
Corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) belong to atypical parkinsonisms (APS) which due to their histopathology are defined as primary tauopathies [7] . It should also be highlighted that AD may be related to accumulation of both . This is one of the aspects allowing neuropathological differentiation between CBD/PSP and frontotemporal lobar degeneration, which is related with three repeats (3R). PSP and less common CBD were described in 1960s (PSP in 1964 , CBD in 1968 -7] as neurodegenerative diseases with relatively short duration and rather difficult differentiation from each other and other extrapyramidal disorders [ 1 2 3 _ T D $ D I F F ] [4] . PSP and CBD due to their similar symptomatology and pathology are often mistaken with each other. Often patients have symptoms characteristic for both diseases.
The aim of the study was to discuss whether strict differentiation of most likely CBS and PSP is justified in all cases. Clinical presentations were correlated with mental dysfunction and neuroimaging.
2.
Material and methods (Tables 1 and 2 ). The presence and stage of ocular motor dysfunction, postural instability, akinesia and cognitive dysfunction were used as basic criteria of the most common subtype of PSP -Richardson syndrome. The certainty of diagnosis was based on the intensity of symptoms. (Table 1) . CBD was examined by assessing the presence and stage of apraxia, alien limb phenomena, cortical sensory loss, cognitive impairment, behavioral changes, and aphasia, asymmetric onset of levodopa-resistant parkinsonism, dystonia, and myoclonus. The more symptoms were present in the clinical examination, the more certain the diagnosis was ( Table 2 ). Symptoms of both diseases were observed among all patients demonstrated in the study. The inclusion and exclusion criteria of both diseases were assessed. In this work 5 case studies of patients with insufficient symptomatology to diagnose either CBD or PSP are demonstrated (Table S1 ). All of these patients were examined by neurologists experienced in movement disorders Based on Ref.
. 
Patient #2
A 65-year-old female patient presented five year history of parkinsonian syndrome which began with bradykinesia at the age of 60. After five years intensive rigidity on the right side appeared. More brisk reflexes and Babinski sign on the right could also be observed. Psychological examination demonstrated disturbed episodic, operational and direct memory and deficits in executive functions. Logopedic examination revealed bradylalia and non-fluent speech. MRI showed disseminated small ischemic regions. Cortical atrophy within the left parietal lobe was observed. MRI also indicated cerebellar atrophy. SPECT imaging revealed limited accumulation of radiotracer within the frontal lobe, mainly on the left side. The patient did not suffer due to any other chronic illness.
Patient #3
A 64-year-old male was admitted to the Department of Neurology due to progressive speech disorders, cognitive impairment, bradykinesia, paresis of right upper limb and balance abnormalities. First symptoms appeared at the age of 59. In neurological examination the patient showed involuntary movement of the right upper limb. The speech was nonfluent due to dysarthria. The patient presented cognitive impairment, bradykinesia and limitations in movements of eyeballs in all directions, deliberative symptoms, bilateral pyramidal syndrome, arrhythmia disturbance and widened asymmetric gait. The logopedic examination confirmed aphasia and dysarthria. The neuropsychological study was dominated by linguistic and frontal disorders. In stabilometric tests gait imbalance was observed. After administration of [ 1 2 8 _ T D $ D I F F ] 200 mg of levodopa no effect on the neurological condition was observed. MR scans revealed asymmetric cortical atrophy mainly in the left lateral sulcus. Atrophy of mesencephalon was also indicated. SPECT examination revealed reduced accumulation of the radiopharmaceutic on the left side within frontal superior and medium gyrus, temporal superior gyrus, Rolandic operculum and insula. The image indicated that the neurodegenerative deterioration might be due to CBS or PSP.
The patient also suffered due to vascular changes in the central nervous system, acute pancreatitis in the past. He was also addicted to alcohol. [ ( I m a g e _ 1 ) T D $ F I G ]
Patient #4
A 65-year-old female patient was admitted to the Department of Neurology for further diagnosis of postural instability with falls, bradykinesia and rigidity of left limbs. First symptoms occurred at the age of 63. In neurological examination cognitive impairment, dysarthria, hypomimia, bradykinesia, hypokinesia more severe in the left limbs, massive rigidity of the left limbs, postural disorders, gait dysfunction, clonuses, bilateral Babinski symptom were observed. Neuropsychological examination revealed dementia. MRI showed small disseminated vascular changes. Moreover signs of marginal cortical degeneration were observed. In SPECT 99mTc-HMPAO examination a decrease in the accumulation of the radiotracer was observed in the occipital lobe, insula and globus pallidus on the left side. Simultaneously normal perfusion on both sides of the thalamus was observed. The patient suffered from cognitive impairments, verbal disorders and hypertension and cervical discopathy.
Patient #5
A 73-year-old female was admitted to the Department of Neurology for extended diagnosis due to involuntary movements within the face, gait disorders, slowness of movement and deteriorating cognitive impairments, which began two years before hospitalization and were followed after one year by falls. The first symptoms appeared at the age of 71. In neurological examination hypokinesia, bradykinesia, rigidity were more intensive on the right side, dystonia of the right foot, cramp of left half of the face, dysarthria, abnormalities in postural reflexes and limited vertical eye movement looking down were found. MRI showed humming bird sign. No other abnormalities in examination of mesencephalon and pons where detected. SPECT 99mTc-HMPAO revealed decreased accumulation within the left thalamus, left inferior parietal gyrus, right cingulate and paracingulate, right thalamus, left superior temporal gyrus, parietal lobe and left middle cingulate and paracingulate. The patient also suffered due to depression, hypertension and hypercholesterolemia.
Discussion
The present case studies indicate that CBD and PSP share similar symptoms. Therefore, their clinical differentiation may be challenging for physicians. Both disorders share some symptoms such as parkinsonian syndrome, aphasia and progressive cognitive impairments. Other symptoms such as asymmetry of symptoms may be subjective or could not differentiate the diseases. These factors create a controversy, whether to differentiate diseases based on clinical symptomatology or to diagnose a disease as most likely CBS variant PSP or most likely PSP variant CBS. Additionally symptoms such as cognitive impairment or progressive dementia not only can be associated with PSP and CBS, but also may be due to vascular disorders which creates another difficulty in examination and proper diagnosis. In a study, in which 39 cases were analyzed, CBS was associated with CBD pathology only in 55% of cases, in 20.5%
with PSP pathology and in 7.2% with Pick[ 1 2 9 _ T D $ D I F F ] 's disease pathology [7] . This may possibly lead to considering the clinical picture of CBS as a marker of tauopathies. On the other hand both CBS and PSP tend to have different histopathological basis. Another study analyzed how CBS was associated with various pathologies (Table S2) . Moreover, vascular pathology mimicking PSP with predominant lower body involvement had been described [ 1 3 6 _ T D $ D I F F ] [13] . Among the types mentioned above, PSP-RS with postural instability, supranuclear gaze palsy and frontal dysfunction and PSP-P associated with asymmetric onset, tremor and limited response to levodopa are the most common. It should also be stressed that some of the patients who never presented ocular motor symptoms, are post mortem diagnosed with PSP 
Conclusion
Taking into account the background of the disease gained from the interview, physical examination and additional studies, all five patients were diagnosed with a neurodegenerative process with cognitive impairments and a parkinsonian syndrome most likely CBD-PSP. Patients with mixed presentation of symptoms of diseases are difficult to classify to one group. This group of patients represents the most conspicuous part of the analysis concerning primary tauopathies with combined symptomatology. Further examination requires extended assessment of a larger group of patients.
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